Guardian Partners’s Bristol-Myers Squibb BMY Stock Holding History

Guardian Partners’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$57.6K	Buy	+1,000	New	+$57.4K	0.01%	273

Other funds holding BMY

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

AIM

Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

FWIA

Fort Washington Investment Advisors Cincinnati, Ohio $19.9B AUM 22.19% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

DLA

Douglas Lane & Associates New York $7.37B AUM 21.9% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

Guardian Partners's BMY Position: Q2 2026 in Review

Guardian Partners opened a new position in Bristol-Myers Squibb (BMY) in Q2 2026: 1,000 shares worth $57.6K. The stake represents 0.01% of the portfolio and ranks #273 among its holdings.

1,038 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

Guardian Partners held 1,000 shares of Bristol-Myers Squibb worth $57.6K as of Q2 2026.
Bristol-Myers Squibb was a new Guardian Partners position in Q2 2026.
Bristol-Myers Squibb made up 0.01% of Guardian Partners's portfolio in Q2 2026, its #273 holding.
1,038 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Guardian Partners's 13F filing for Q2 2026, filed 29 Jul 2026.